Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,603 | -15,616 | -62,025 | -49,123 | -34,569 |
| Depreciation Amortization | 117 | 52 | 212 | 166 | 118 |
| Accounts payable and accrued liabilities | 137 | 296 | -886 | 287 | -756 |
| Other Working Capital | -4,267 | 1,842 | -3,444 | -2,165 | -1,777 |
| Other Operating Activity | 5,814 | 3,982 | 9,506 | 5,429 | 4,152 |
| Operating Cash Flow | $-22,802 | $-9,444 | $-56,637 | $-45,406 | $-32,832 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,000 | 30,000 | -29,938 | -56,938 | -75,954 |
| PPE Investments | N/A | N/A | -16 | -16 | -16 |
| Investing Cash Flow | $30,000 | $30,000 | $-29,955 | $-56,955 | $-75,971 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 58 | 53 | 1,220 | 1,220 | 23 |
| Financing Cash Flow | $58 | $53 | $1,220 | $1,220 | $23 |
| Beginning Cash Position | 144,419 | 144,419 | 229,791 | 229,791 | 229,791 |
| End Cash Position | 151,676 | 165,028 | 144,419 | 128,651 | 121,012 |
| Net Cash Flow | $7,256 | $20,609 | $-85,372 | $-101,140 | $-108,779 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,802 | -9,444 | -56,637 | -45,406 | -32,832 |
| Capital Expenditure | N/A | N/A | -16 | -16 | -16 |
| Free Cash Flow | -22,802 | -9,444 | -56,654 | -45,422 | -32,848 |